Notably, in a previous study, C3ar1 (C3a receptor) deletion rescued tau pathology and attenuated neuroinflammation, synaptic deficits, and neurodegeneration in the PS19 tauopathy mouse model [24]. The gene discussed is C3AR1; the disease is tauopathy.